Table 4.
Multiple Cox regression analysis for study outcomes.
| Outcomes | Hazard ratio | 95%CI | P |
|---|---|---|---|
| MACE (n = 205) | |||
| COPD | 3.290 | 2.276–4.756 | 0.0001 |
| hs-CRP | 1.050 | 1.009–1.093 | 0.017 |
| Total stroke (n = 77) | |||
| COPD | 9.119 | 4.631–17.958 | 0.0001 |
| hs-CRP | 1.075 | 1.010–1.145 | 0.024 |
| Non fatal stroke (n = 63) | |||
| COPD | 10.908 | 5.108–23.295 | 0.0001 |
| hs-CRP | 1.082 | 1.010–1.160 | 0.026 |
| MI (n = 117) | |||
| COPD | 1.928 | 1.228–3.030 | 0.004 |
| e-GFR | 0.864 | 0.787–0.949 | 0.002 |
| Non fatal MI (n = 111) | |||
| COPD | 1.886 | 1.189–2.992 | 0.007 |
| e-GFR | 0.871 | 0.792–0.957 | 0.004 |
Data are adjusted for: age, gender, body mass index, smoking, systolic blood pressure, fasting plasma glucose, HDL-cholesterol, e-GFR, hs-CRP, and blood pressure target achievement during pharmacological treatment (yes/no). COPD: chronic obstructive pulmonary disease; e-GFR: estimated glomerular filtration rate; hs-CRP: high sensitivity C reactive protein; MI: myocardial infarction.